FDA chief defends Zohydro approval as US states rebel.
Seattle.
Michael
M
McCarthy
D000701:Analgesics, Opioid / Q000627:therapeutic use*; D059350:Chronic Pain / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D017277:Drug Approval; D006801:Humans; D006853:Hydrocodone / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D006853:Hydrocodone